Qualigen Therapeutics Inc (QLGN) — Cash Flow Reinvestment Rate
Qualigen Therapeutics Inc (QLGN) has a Cash Flow Reinvestment Rate of 4.81x as of September 2023, reinvesting $4.47 Million (capex $246.42K plus investments $4.23 Million) from operating cash flow of $929.74K. Explore capital reinvestment ratio of Qualigen Therapeutics Inc to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Qualigen Therapeutics Inc Cash Flow Reinvestment Rate (2019–2019)
Historical reinvestment intensity for Qualigen Therapeutics Inc across 1 annual periods. Also explore Qualigen Therapeutics Inc balance sheet assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Qualigen Therapeutics Inc (2019–2019)
Year-by-year capital reinvestment analysis for Qualigen Therapeutics Inc. For live market cap and broader valuation context, see Qualigen Therapeutics Inc stock valuation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2019 | 6.78x | $388.95K | $57.33K | $194.48K | — |